Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Clinical trials with Ad26COVS1

Proposed period of release:
01/01/2020 to 01/01/2021

Name of the Institute(s) or Company(ies)
University Medical Center Utrecht, University Medical Center Utrecht;

3. Is the same GMO release planned elsewhere in the Community?
Germany; Spain;

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The identity of the GMO is Ad26COVS1 and is a replication incompetent adenovirus vector containing the sequence for the spike (S) protein of SARS-CoV-2. The Ad26COVS1 vector is derived from the human adenovirus group D type 26 (genus Mastadenoviridae).

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Ad26MastadenovirusHuman adenovirus group D-Type 26-

European Commission administrative information

Consent given by the Member State Competent Authority:
10/07/2020 00:00:00